Cargando…
Iron distribution in different tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments
Iron‐refractory iron deficiency anemia (IRIDA) is an autosomal recessive disorder caused by genetic mutations on TMPRSS6 gene which encodes Matriptase2 (MT2). An altered MT2 cannot appropriately suppress hepatic BMP6/SMAD signaling in case of low iron, hence hepcidin excess blocks dietary iron absor...
Autores principales: | Asperti, Michela, Brilli, Elisa, Denardo, Andrea, Gryzik, Magdalena, Pagani, Francesca, Busti, Fabiana, Tarantino, Germano, Arosio, Paolo, Girelli, Domenico, Poli, Maura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292262/ https://www.ncbi.nlm.nih.gov/pubmed/34343368 http://dx.doi.org/10.1002/ajh.26311 |
Ejemplares similares
-
Sucrosomial(®) Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation
por: Asperti, Michela, et al.
Publicado: (2018) -
The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells
por: Asperti, Michela, et al.
Publicado: (2019) -
The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo
por: Asperti, Michela, et al.
Publicado: (2023) -
Hepatic heparan sulfate is a master regulator of hepcidin expression and iron homeostasis in human hepatocytes and mice
por: Poli, Maura, et al.
Publicado: (2019) -
Sucrosomial(®) Iron: An Updated Review of Its Clinical Efficacy for the Treatment of Iron Deficiency
por: Gómez-Ramírez, Susana, et al.
Publicado: (2023)